Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Malabsorption Syndromes » Celiac Disease
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Malabsorption Syndromes » Celiac Disease
Description
A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION. MeSH
Hierarchy View
Approved Indicated Drugs (2)
Phase 4 Indicated Drugs (14)
Phase 3 Indicated Drugs (1)
Phase 2 Indicated Drugs (10)
Phase 1 Indicated Drugs (7)
Other Experimental Indicated Drugs (9)
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (38)
AGA Clinical Research Associates, LLC
Cour Pharmaceutical Development Company, Inc.
Global Institute of Probiotics
Gobierno Autónomo de Buenos Aires
James Cook University Hospital, Middlesbrough, UK
National Center for Complementary and Integrative Health (NCCIH)
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (18)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
